SkinHealth Systems SKIN Income Statement (2020-2026)

NASDAQ SKIN
$0.74 +0.05 (+7.61%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

SkinHealth Systems Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

SkinHealth Systems reported revenue of $72.11M and net income of -$2.67M for the quarter ended Jun 2026, down 7.8% year over year. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
68.15M77.89M75.42M103.54M88.79M98.13M86.28M117.48M97.41M96.82M81.40M90.59M78.80M83.50M69.58M78.19M70.66M82.37M64.91M72.11M
Cost of RevenueCost of Rev
22.07M24.42M24.53M33.50M27.43M31.64M32.17M49.60M109.97M51.13M33.04M49.65M38.15M31.15M21.00M29.07M25.02M29.33M20.47M22.77M
Gross Profit
46.08M53.47M50.88M70.04M61.36M66.49M54.10M67.88M-12.55M45.69M48.36M40.94M40.65M52.35M48.58M49.11M45.63M53.04M44.44M49.34M
Operating items
Research & DevelopmentR&D
30.45M37.05M36.41M44.88M39.77M39.02M38.70M43.04M30.73M32.02M33.68M30.48M27.62M26.52M26.04M23.11M20.93M23.51M23.20M21.02M
Selling, General & AdministrativeSG&A
19.20M25.05M26.26M27.59M23.78M28.47M30.38M35.10M36.98M28.98M28.86M31.41M33.44M31.76M33.56M27.45M29.25M27.68M21.94M23.34M
Other Operating ExpensesOther Opex
1.88M1.88M2.23M2.60M2.17M1.45M2.34M2.88M1.84M3.05M2.81M1.16M1.11M1.22M1.00M1.25M1.70M1.68M1.10M1.41M
Operating ExpensesOpex
51.53M63.97M64.90M75.07M65.72M68.94M71.41M81.02M69.55M64.05M65.35M63.05M62.16M59.50M60.60M51.81M51.88M52.88M46.24M45.77M
Operating IncomeOp. Inc
-5.46M-10.50M-14.01M-5.03M-4.35M-2.45M-17.31M-13.15M-82.10M-18.36M-16.99M-22.11M-21.52M-7.16M-12.02M-2.70M-6.24M0.16M-1.80M3.57M
EBIT
-5.46M-10.50M-14.01M-5.03M-4.35M-2.45M-17.31M-13.15M-82.10M-18.36M-16.99M-22.11M-21.52M-7.16M-12.02M-2.70M-6.24M0.16M-1.80M3.57M
Non-operating items
Non Operating Interest Expenses
3.40M3.22M3.38M3.40M3.42M3.43M3.44M3.36M3.03M2.45M2.47M2.46M2.50M4.14M6.31M6.37M6.35M6.29M
Non Operating Investment IncomeNon-Op. Investment Inc.
Interest & Investment IncomeInt & Inv Inc
-0.53M8.33M-0.00M0.74M2.87M5.57M4.32M5.72M6.75M6.39M5.36M4.19M4.88M2.22M3.03M3.16M1.26M1.51M1.49M1.29M
Other Non Operating IncomeOther Non Op Inc.
-0.43M-0.20M-0.93M-2.21M-0.36M0.15M1.15M0.40M4.87M-0.14M16.09M17.32M2.28M0.09M1.88M18.15M0.60M0.12M-1.20M-0.05M
Non Operating IncomeNon Op. Inc.
-210.82M-9.04M48.08M11.42M3.45M
Net income details
EBT
-216.27M-19.54M34.07M6.39M-0.90M5.78M-23.92M1.17M-70.34M-8.80M-1.34M-0.15M-16.34M-11.72M-9.20M18.72M-10.64M-4.81M-6.81M-1.46M
Tax ProvisionsTaxes
-1.13M1.43M2.62M0.10M-0.82M-0.79M-3.70M-2.20M3.50M0.63M-0.70M-0.40M1.95M-1.39M0.90M-1.00M0.40M3.28M-0.20M1.21M
Profit After TaxPAT
-216.68M-20.65M31.45M6.32M-1.72M6.53M-20.26M3.36M-74.91M-8.83M-0.68M0.20M-18.29M-13.57M-10.10M23.34M-11.03M-13.28M-6.63M-2.67M
Income from Continuing OperationsIncome (Continuing)
-215.15M-20.97M31.45M6.29M-0.08M6.56M-20.22M3.37M-73.84M-9.43M-0.64M0.25M-18.29M-10.33M-10.10M19.72M-11.04M-8.09M-6.61M-2.67M
Consolidated Net IncomeConsol Net Inc.
-215.15M-20.97M31.45M6.29M-0.08M6.56M-20.22M3.37M-73.84M-9.43M-0.64M0.25M-18.29M-10.33M-10.10M19.72M-11.04M-8.09M-6.61M-2.67M
Income towards Parent CompanyParent Net Inc
-215.15M-20.97M31.45M6.29M-0.08M6.56M-20.22M3.37M-73.84M-9.43M-0.64M0.25M-18.29M-10.33M-10.10M19.72M-11.04M-8.09M-6.61M-2.67M
Net Income towards Common StockholdersNet Income
-215.15M-20.97M31.45M6.29M-0.08M6.56M-20.22M3.37M-73.84M-9.43M-0.64M0.25M-18.29M-10.33M-10.10M19.72M-11.04M-8.09M-6.61M-2.67M
Additional items
EPS (Basic)
-1.63-0.210.210.040.000.04-0.150.03-0.56-0.07-0.010.00-0.15-0.08-0.080.16-0.09-0.06-0.05-0.02
EPS (Diluted)
-1.63-0.210.210.040.000.04-0.150.03-0.56-0.070.000.00-0.15-0.07-0.080.14-0.09-0.06-0.05-0.02
Shares Outstanding
132.31M102.11M150.60M150.73M150.79M147.55M132.42M132.72M132.90M131.68M123.12M123.72M124.06M123.83M125.08M126.07M126.89M126.38M127.79M129.60M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
132.31M102.11M152.71M151.72M151.42M148.51M132.42M132.72M132.90M131.68M144.48M141.93M124.06M142.49M125.08M140.29M126.89M135.80M131.40M129.60M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
133.49M136.83M150.60M150.86M143.20M132.21M132.63M132.88M132.57M122.90M123.45M123.99M124.11M124.92M125.25M126.76M127.30M127.52M129.14M130.10M
EBITDA
-5.46M-10.50M-14.01M-5.03M-4.35M-2.45M-17.31M-13.15M-82.10M-18.36M-16.99M-22.11M-21.52M-7.16M-12.02M-2.70M-6.24M0.16M-1.80M3.57M
Interest ExpensesInt Expense
3.40M3.22M3.38M3.40M3.42M3.43M3.44M3.36M3.03M2.45M2.47M2.46M2.50M4.14M6.31M6.37M6.35M6.29M
Tax Rate
0.52%-7.32%7.68%1.56%91.02%-13.59%15.47%-187.87%-4.98%-7.13%52.32%264.90%-11.92%11.85%-9.78%-5.34%-3.76%-68.24%2.94%-82.68%